A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

“Tuberculosis cells are clumpy and seem to always stick close to each other, so defining cell boundaries didn’t seem possible,” said Sugie, chief technology officer at Linnaeus Bioscience. “Instead, ...

Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel ...

As Kansas deals with one of the largest tuberculous outbreaks in the nation since the 1950s, Californians may be wondering whether they’re at risk. The Kansas outbreak, described by health officials ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including Mycobacterium tuberculosis ...

13 million. That’s how many people the CDC estimates live in the U.S. with inactive tuberculosis. If they don’t get treatment, about one in 10 of those people will get active TB. Most ...

Kansas is currently facing one the largest tuberculosis outbreaks in U.S. history with 67 confirmed active cases and 79 ...